Abstract
Post-Traumatic Stress Disorder (PTSD) is a complex psychiatric condition with high heritability, yet identifying specific risk genes has proven challenging due to phenotypic heterogeneity. This study employs transcriptomic imputation (TI) to bridge the gap between genomic variants and biological function. By analyzing large-scale genetic data stratified by trauma type, we identified SNRNP35 as a study-wide significant risk gene specifically associated with military-related PTSD. Our findings indicate that SNRNP35 downregulation—mediated by both genetic predisposition and environmental stress—disrupts minor spliceosome function in the prefrontal cortex. This suggests that the genetic architecture of PTSD may vary significantly depending on the nature of the trauma experienced.
Introduction
Post-Traumatic Stress Disorder (PTSD) is characterized by a heritability estimated between 30% and 71%. Despite this, traditional Genome-Wide Association Studies (GWAS) have faced difficulties in identifying reproducible genetic markers and clarifying the functional roles of risk loci. A significant hurdle is the heterogeneity of the disorder; clinical trajectories and symptoms vary widely across different trauma types, such as combat exposure versus civilian trauma.
This study addresses whether the genetic risk for PTSD is similarly heterogeneous. By moving beyond individual DNA variants to examine Genetically Regulated Gene Expression (GReX), the researchers sought to identify tissue-specific gene expression patterns associated with PTSD risk across different trauma-exposed populations.
Methods
The researchers utilized Transcriptomic Imputation (TI), specifically the PrediXcan and S-PrediXcan frameworks, to predict gene expression levels based on genotype. This approach allows for the identification of genes likely to be differentially expressed in specific tissues, such as the brain, in individuals with high genetic risk.
Data and Stratification
The discovery phase utilized GWAS data from the PGC-PTSD consortium, comprising 9,087 cases and 23,811 controls. Reference panels from the Genotype-Tissue Expression (GTEx) project and the CommonMind Consortium (CMC) were used to build imputation models for 22 tissues, including 11 brain regions. Crucially, meta-analyses were stratified into military and civilian cohorts to investigate trauma-specific effects.
Validation Strategies
To validate the computational findings, the study integrated multiple experimental lines:
- Human Longitudinal Data: Predicted expression was compared against actual RNA-seq data from the Marine Resiliency Study (MRS), which tracked 175 Marines pre- and post-deployment.
- Cellular Models: shRNA-mediated knockdown of SNRNP35 was performed in human HEK293 cells to assess the impact on RNA splicing.
- Animal Models: Adult male C57BL/6J mice were treated with dexamethasone to simulate acute stress-axis activation and observe changes in Snrnp35 expression.
Results
Identification of SNRNP35
The primary finding was the identification of SNRNP35 in the BA9 region of the prefrontal cortex as a study-wide significant hit ($p = 8.85 \times 10^{-8}$) specifically within military cohorts. Notably, this signal was absent in civilian cohorts, suggesting a distinct genetic architecture underlying military-related PTSD. In all significant associations, the downregulation of SNRNP35 was linked to increased PTSD risk.
Functional Impact on the Minor Spliceosome
SNRNP35 encodes a subunit of the minor spliceosome, a specialized machinery responsible for processing U12-type introns. While these introns are rare (found in ~0.5% of human genes), they are often located in genes critical for cellular function. Experimental knockdown of SNRNP35 in cell culture specifically impaired the splicing of U12-type introns (e.g., in the CHD1L gene) while standard U2-type splicing remained unaffected.
Convergence of Genetics and Environment
The study observed a "double hit" mechanism for SNRNP35 downregulation. Beyond the genetic predisposition identified via TI, environmental factors also suppressed the gene. In the MRS cohort, deployment itself was associated with decreased SNRNP35 expression. Similarly, in the mouse model, dexamethasone-induced stress significantly downregulated Snrnp35 in the prefrontal cortex ($p = 0.0303$). This suggests that both "nature" (genetics) and "nurture" (stress) converge on the same biological pathway to increase PTSD vulnerability.
Discussion
These findings highlight SNRNP35 as a novel risk factor for PTSD, particularly in the context of military trauma. The specificity of this signal to military cohorts suggests that PTSD may not be a monolithic biological entity. Instead, different types of trauma may engage distinct genetic and molecular pathways.
Limitations
The study's military cohorts were primarily composed of males of European ancestry, which may limit the generalizability of the SNRNP35 finding to other demographics. Additionally, using "Military" vs. "Civilian" as a proxy for trauma type is a simplification, as individuals in both groups may experience overlapping types of trauma.
Future Directions
Future research should investigate the specific downstream targets of disrupted U12-splicing in the brain. Identifying which proteins are mis-spliced when SNRNP35 levels are low could reveal new therapeutic targets for treating or preventing PTSD in high-risk populations.
Summary updated